These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9310221)

  • 41. The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple sclerosis: 4-year data from the PRISMS study.
    Gold R; Rieckmann P; Chang P; Abdalla J;
    Eur J Neurol; 2005 Aug; 12(8):649-56. PubMed ID: 16053475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Condylomata acuminata--topical and systemic interferon therapy].
    Fierlbeck G; Breuninger H; Fierlbeck B; Rassner G
    Hautarzt; 1991 Jan; 42(1):39-43. PubMed ID: 1707042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of female genital condylomatosis with intramuscular beta interferon].
    Fallani MG; Penna C; Sonni L; Gordigiani R; Cioffi M; Cesario L; Maggiorelli M; Marchionni M
    Minerva Ginecol; 1991 Dec; 43(12):595-9. PubMed ID: 1819779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary treatment of condylomata acuminata with viable bacillus Calmette-Guerin.
    Böhle A; Büttner H; Jocham D
    J Urol; 2001 Mar; 165(3):834-6. PubMed ID: 11176481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH
    Mult Scler; 1995 Jun; 1(2):118-35. PubMed ID: 9345462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Recombinant alpha and/or gamma interferon in the treatment of 45 patients with condylomata acuminata].
    Reichel R; Fitz R; Denison U; Genger H; Vavra N
    Gynakol Rundsch; 1989; 29 Suppl 2():350-1. PubMed ID: 2515124
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study.
    Bellingan G; Maksimow M; Howell DC; Stotz M; Beale R; Beatty M; Walsh T; Binning A; Davidson A; Kuper M; Shah S; Cooper J; Waris M; Yegutkin GG; Jalkanen J; Salmi M; Piippo I; Jalkanen M; Montgomery H; Jalkanen S
    Lancet Respir Med; 2014 Feb; 2(2):98-107. PubMed ID: 24503265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: results of an open-label multicentre study.
    Kowalzick L; Rogozinski T; Wimheuer R; Pilz J; Manske U; Scholz A; Fierlbeck G; Mohr P; Ochsendorf F; Wagner G; Gaus W; Brzoska J; Jablonska S
    Eur J Dermatol; 2002; 12(6):558-61. PubMed ID: 12459527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful treatment of condylomata acuminata and bowenoid papulosis with subcutaneous injections of low-dose recombinant interferon-alpha.
    Gross G; Roussaki A; Schöpf E; De Villiers EM; Papendick U
    Arch Dermatol; 1986 Jul; 122(7):749-50. PubMed ID: 3729505
    [No Abstract]   [Full Text] [Related]  

  • 50. Subcutaneous interferon alpha in the treatment of refractory condylomata.
    Paavonen J
    Sex Transm Dis; 1990; 17(3):152-3. PubMed ID: 2247806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study.
    Khatri B; Barkhof F; Comi G; Hartung HP; Kappos L; Montalban X; Pelletier J; Stites T; Wu S; Holdbrook F; Zhang-Auberson L; Francis G; Cohen JA;
    Lancet Neurol; 2011 Jun; 10(6):520-9. PubMed ID: 21571593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
    Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.
    Sorensen PS; Mellgren SI; Svenningsson A; Elovaara I; Frederiksen JL; Beiske AG; Myhr KM; Søgaard LV; Olsen IC; Sandberg-Wollheim M
    Lancet Neurol; 2009 Jun; 8(6):519-29. PubMed ID: 19409854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Intramuscular beta-interferon therapy of patients with genital HPV infection].
    Sartor V; Spairani L; Gini A; Delpiano C
    Minerva Ginecol; 1993 Jun; 45(6):321-5. PubMed ID: 8395033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The treatment with intramuscular interferon of female genital condylomatosis: beta-IFN vs alfa-2a-IFN].
    Bernasconi F; Galli F; Ersettigh G; Arienti S
    Minerva Ginecol; 1995 Apr; 47(4):147-54. PubMed ID: 7644096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized clinical trial comparing systemic interferon with diathermocoagulation in primary multiple and widespread anogenital condyloma.
    Benedetti Panici P; Scambia G; Baiocchi G; Perrone L; Pintus C; Mancuso S
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):393-7. PubMed ID: 2761917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, double-blind trial of parenteral low dose versus high dose interferon-beta in combination with cryotherapy for treatment of condyloma acuminatum.
    Bonnez W; Oakes D; Bailey-Farchione A; Choi A; Hallahan D; Corey L; Barnum G; Pappas PG; Halloway M; Stoler MH; Reichman RC
    Antiviral Res; 1997 Jun; 35(1):41-52. PubMed ID: 9224960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon alpha-2b dependent recalcitrant genital warts.
    Larsen J; Petersen CS; Kroon S
    Dan Med Bull; 1990 Aug; 37(4):374-5. PubMed ID: 2245662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical interferon for treating condyloma acuminata in women.
    Keay S; Teng N; Eisenberg M; Story B; Sellers PW; Merigan TC
    J Infect Dis; 1988 Nov; 158(5):934-9. PubMed ID: 2460568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical liposomal tetracaine for pain relief of intralesional interferon injections in the treatment of condylomata acuminata.
    Foldvari M; Moreland A; Smith T
    Int J Dermatol; 1992 Dec; 31(12):894-5. PubMed ID: 1282502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.